颈动脉内膜切除术后患者的长期死亡率
这项两中心非随机观察性研究纳入1998至2017年瑞典斯德哥尔摩1033例颈动脉内膜切除术患者,随访6.6±4.8年,比较无症状与有症状患者长期全因死亡率。结果显示两组总体死亡率相似(34.2% vs 33.7%,p=.89),有症状疾病未影响死亡风险(校正HR 1.14,95%CI 0.81-1.62)。女性前10年粗死亡率低于男性(20.8% vs 27.6%,p=.019)。
要点
- 无症状与有症状颈动脉内膜切除术患者长期死亡率相似(34.2% vs 33.7%,p=.89)。
- 有症状疾病未显著影响死亡风险(校正HR 1.14,95%CI 0.81-1.62)。
- 女性前10年粗死亡率低于男性(20.8% vs 27.6%,p=.019)。
核心结论
- 有症状与无症状颈动脉患者颈动脉内膜切除术后长期死亡率相似,但男性结局较女性差。
- 性别、年龄和术后时间影响标准化死亡比。
- 作者认为这些结果强调需要针对性二级预防,以改变颈动脉内膜切除术患者的长期不良影响。
研究设计与样本
- 两中心、非随机、观察性研究,评估1998至2017年瑞典斯德哥尔摩颈动脉内膜切除术患者的长期全因死亡率。
- 共纳入1033例患者,随访6.6±4.8年,死亡和合并症从国家登记和医疗记录中提取。
- 采用Cox回归分析临床特征与结局的关联,并研究性别差异和年龄性别匹配的标准化死亡比(SMR)。
主要发现
- 随访期间349例患者死亡,无症状与有症状患者总体死亡率相似(34.2% vs 33.7%,p=.89)。
- 有症状疾病未影响死亡风险(校正HR 1.14,95%CI 0.81-1.62)。
- 女性前10年粗死亡率低于男性(20.8% vs 27.6%,p=.019)。
- 女性中,心脏病与死亡率增加相关(校正HR 3.55,95%CI 2.18-5.79);男性中,降脂药物具有保护作用(校正HR 0.61,95%CI 0.39-0.96)。
- 术后前5年内,所有患者SMR均升高(男性1.50,95%CI 1.21-1.86;女性2.41,95%CI 1.74-3.35),<80岁患者亦升高(SMR 1.46,95%CI 1.23-1.73)。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: Carotid endarterectomy (CEA) is an effective surgical method for stroke prevention in selected patients with carotid stenosis. Few contemporary studies report on the long term mortality rate in CEA treated patients, despite continuous changes in medication, diagnostics, and patient selection. Here, the long term mortality rate is described in a well characterised cohort of asymptomatic and symptomatic CEA patients, sex differences evaluated, and mortality ratio compared with the general population. METHODS: This was a two centre, non-randomised, observational study evaluating all cause, long term mortality in CEA patients from Stockholm, Sweden between 1998 and 2017. Death and comorbidities were extracted from national registries and medical records. Cox regression was adapted to analyse associations between clinical characteristics and outcome. Sex differences and standardised mortality ratio (SMR, age and sex matched) were studied. RESULTS: A total of 1 033 patients were followed for 6.6 ± 4.8 years. Of those, 349 patients died during follow up where the overall mortality rate was similar in asymptomatic and symptomatic patients (34.2% vs. 33.7%, p = .89). Symptomatic disease did not influence the mortality risk (adjusted HR 1.14, 95% CI 0.81 - 1.62). Women had lower crude mortality rate than men in the first 10 years (20.8% vs. 27.6%, p = .019). In women, cardiac disease was associated with increased mortality (adjusted HR 3.55, 95% CI 2.18 - 5.79), while in men, lipid lowering medication was protective (adjusted HR 0.61, 95% CI 0.39 - 0.96). Within the first five years after surgery, SMR was increased for all patients (men 1.50, 95% CI 1.21 - 1.86; women 2.41, 95% CI 1.74 - 3.35), as well as in patients < 80 years (SMR 1.46, 95% CI 1.23 - 1.73). CONCLUSION: Symptomatic and asymptomatic carotid patients have similar long term mortality rates after CEA, but men had worse outcome than women. Sex, age, and time after surgery were shown to influence SMR. These results highlight the need for targeted secondary prevention, to alter the long term adverse effects in CEA patients.
引用
- Wadén K, Hultgren R, Kotopouli MI, et al. Long Term Mortality Rate in Patients Treated with Carotid Endarterectomy. Eur J Vasc Endovasc Surg. 2023. PMID: 36871924. doi:10.1016/j.ejvs.2023.02.079
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。